Reviewed by the PeptideMind Team · Updated August 6, 2026

CJC-1295 vs Sermorelin:
Key differences comparison

CJC-1295 and Sermorelin are both GHRH analogues that tell the pituitary gland to release growth hormone, but they differ mainly in how long each one lasts in the body. CJC-1295 (with DAC) binds to a protein in the blood called albumin, stretching its half-life to about 7 days so it's usually injected once weekly. Sermorelin has a much shorter half-life of about 12 minutes and is typically injected once nightly at bedtime to match the body's natural overnight growth hormone pulse.

Growth

cjc1

Growth

CJC-1295 with DAC

VS

Growth

ser

Growth

Sermorelin

Experimental

WeightGrowth

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

What Is CJC-1295?

CJC-1295 is a lab-made version of growth hormone releasing hormone (GHRH), the natural signal your pituitary gland uses to release growth hormone. The version most people mean when they say "CJC-1295" includes a chemical tag called DAC (Drug Affinity Complex), which lets it latch onto a protein already circulating in your blood. That tag is what stretches its effects from minutes to about a week, which is why it's typically injected only once or twice weekly instead of daily.

A longer-lasting design

The DAC tag lets CJC-1295 bind to albumin, a protein always present in blood, turning it into a slow-release depot that keeps growth hormone elevated for days instead of minutes. Its half-life in our data runs about 168 hours, or roughly 7 days.

What it's best known for

Sustained growth hormone and IGF-1 elevation for muscle building, recovery, and body composition goals, often studied alongside a companion peptide like Ipamorelin.

Where it stands legally

CJC-1295 has no FDA approval for any use. It's sold online strictly as an unregulated research chemical, not intended for people to use on themselves.

Infographic titled 'What Is CJC-1295?' on a smartphone screen showing three cards for its studied effects: growth hormone release, recovery and sleep, and body composition.

What Is Sermorelin?

Sermorelin is a lab-made peptide based on the active portion of the same natural hormone, GHRH. It was originally FDA-approved under the brand name Geref for diagnosing and treating growth hormone deficiency in children, but that approval was discontinued and pulled from the US market in 2002. Today it's available through compounding pharmacies with a prescription and used off-label for anti-aging, sleep, and body composition support.

A gentler, shorter-acting design

Sermorelin clears the body in about 12 minutes and is typically injected at a lower dose right before bed, timed to align with the body's natural nighttime growth hormone pulse.

What it's best known for

Sleep quality, recovery, and general anti-aging support, along with modest gains in lean muscle. It was first studied for pediatric growth hormone deficiency.

Where it stands legally

No longer sold as an FDA-approved drug in the US since 2002. Sermorelin is available through compounding pharmacies with a prescription for off-label adult use.

Infographic titled 'What Is Sermorelin?' on a smartphone screen showing cards for GHRH-based peptide, ~12-minute half-life, and known uses: sleep, recovery, and healthy aging support.

CJC-1295 vs Sermorelin at a Glance

A side-by-side look at how CJC-1295 and Sermorelin differ in how they work, how they're dosed, and where each stands legally.

Growth

cjc1

Weight

CJC-1295 with DAC

Overview

Type
Single peptide
Primary category
Growth
Secondary categories
Weight
Research status
Phase 2
FDA approved
Not FDA approved
Popularity
5/10
Body targets
HormonesMuscle
Price range
Human trial status
Human RCTs
Legal status
Research chemical
WADA status
Banned

Dosing

Dose
1–2 mg
Frequency
Weekly
Cycle
8–12 weeks
Route of administration
Subcutaneous
Common vial sizes
2mg5mg

Research

Molecular weight
3647.25 g/mol
Half-life
168 hrs
Median onset
Prescription alternative
Has alternative
Receptor target
GHRHR
Receptor action
Agonist
Mechanistic pathways
GHRH GH AXIS

Included in

Not part of any blends yet.

Growth

ser

Weight

Sermorelin

Experimental

WeightGrowth

Overview

Type
Single peptide
Primary category
Growth
Secondary categories
Weight
Research status
Experimental
FDA approved
Not FDA approved
Popularity
10/10
Body targets
Hormones
Price range
Human trial status
Human RCTs
Legal status
Prescription required
WADA status
Banned

Dosing

Dose
200–500 mcg
Frequency
5 days on / 2 off
Cycle
8–12 weeks on / 4 weeks off
Route of administration
Subcutaneous
Common vial sizes
2mg5mg+1

Research

Molecular weight
3358 g/mol
Half-life
0.2 hrs
Median onset
Prescription alternative
Has alternative
Receptor target
GHRHR
Receptor action
Agonist
Mechanistic pathways
GHRH GH AXIS

Included in

Not part of any blends yet.

Our top-rated vendor

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

Visit site
View all vendors

Comparison at a Glance: CJC-1295 vs Sermorelin

A quick side-by-side look at how CJC-1295 and Sermorelin differ in how long they last, how growth hormone is released, and where each stands legally.

Half-life and dosing schedule

CJC-1295 (with DAC) has a half-life of about 7 days, so it's injected once or twice weekly. Sermorelin clears the body in about 12 minutes, so it's injected daily, usually right before bed.

How growth hormone is released

Sermorelin's short half-life produces one clean pulse of growth hormone per dose, closely matching the body's natural rhythm. CJC-1295's DAC tag keeps levels elevated continuously for days, trading that pulsatile pattern for convenience.

Legal access

Sermorelin requires a prescription and is available through compounding pharmacies for off-label use. CJC-1295 has no FDA approval for any use and is sold only as a research chemical, not through a pharmacy.

Research evidence

Both peptides have human clinical trial data behind the GHRH pathway they use, but Sermorelin's original approval was for diagnosing and treating growth hormone deficiency in children, while CJC-1295 has been studied mainly as a longer-acting research compound.

CJC-1295 vs Sermorelin comparison graphic on a smartphone screen showing icons for half-life, GH release pattern, dosing schedule, and legal status.

CJC-1295 with DAC Dosage Guide for Fat Loss / Muscle

CJC-1295 with DAC is a long-acting peptide that keeps growth hormone levels steadily elevated over time.

Vial size

2 mg

Bacteriostatic water

2 mL

Dosing

1–2 mg

Frequency

Weekly

Cycle

8–12 weeks

Benefit

Fat Loss / Muscle

Explore calculators

Sermorelin Dosage Guide for Muscle Growth

Sermorelin encourages your body to release more of its own growth hormone. It's injected at night on an empty stomach, 30 to 60 minutes before bed, to line up with the body's natural overnight growth hormone release. Most protocols start at 200 to 300 mcg and increase by about 100 mcg every week or two.

Vial size

5 mg

Bacteriostatic water

3 mL

Dosing

200–500 mcg

Frequency

5 days on / 2 off

Cycle

8–12 weeks on / 4 weeks off

Benefit

Muscle Growth

Explore calculators

CJC-1295 vs Sermorelin: Which One Should You Research?

Because both act on the same GHRH receptor, CJC-1295 and Sermorelin are considered alternatives to each other rather than stack partners. Researchers who want to combine a GHRH analogue with something else more commonly pair either one with a ghrelin-receptor peptide like Ipamorelin, which works through a different pathway.

If dosing convenience matters more

CJC-1295 (with DAC) is reported to sustain growth hormone and IGF-1 elevation for days per dose, cutting injection frequency down to once or twice a week instead of daily.

If a natural, pulsatile pattern and prescription access matter more

Sermorelin more closely mimics the body's natural overnight GH pulse and is available through a compounding pharmacy with a prescription, rather than only as a research chemical.

Neither is approved for anti-aging or bodybuilding use

Sermorelin's original FDA approval covered only pediatric growth hormone deficiency and was later withdrawn from the market. CJC-1295 has never held FDA approval for any use. Research-grade versions of both are sold strictly for research, not for people to use on themselves.

Infographic titled 'CJC-1295 vs Sermorelin' on a phone screen listing research focus areas: GH support, recovery, sleep, and long-acting duration.

Frequently Asked Questions: CJC-1295 vs Sermorelin

Straight answers on how CJC-1295 and Sermorelin compare, and how each is dosed. For research reference only.

CJC-1295 vs Sermorelin: Dosing Basics

Both peptides raise growth hormone through the same receptor, but the injection schedule looks very different because of how long each one stays active in the body.

CJC-1295 (with DAC) dosing

Commonly discussed at 1 to 2 mg per injection, given once weekly thanks to its roughly 7-day half-life. Research protocols often run 8 to 12 weeks before a break.

Sermorelin dosing

Commonly discussed at 200 to 500 mcg per injection, often run on a 5-days-on, 2-days-off schedule at bedtime. Research protocols often run 8 to 12 weeks on, followed by about 4 weeks off.

Use a peptide-specific calculator

How concentrated the vial is and how much liquid you mix in changes the actual draw for both peptides. Use a dosage calculator to get an exact number instead of guessing from a general range.

'Dosing Basics' phone screen graphic comparing CJC-1295's 1-2 mg weekly dose to Sermorelin's 200-500 mcg dose given 5 days on, 2 days off.

Results Timeline: What to Expect Week by Week

Timelines vary by person, dose, and which peptide is used, but trial data and research write-ups describe a similar general pattern for both.

Weeks 1 to 4

IGF-1 levels begin rising for both peptides within the first two weeks, often alongside improved sleep quality and energy. Mild joint discomfort or injection-site reactions are sometimes reported early on with either compound.

Weeks 4 to 8

CJC-1295 users often describe steadier energy and recovery building over this window as weekly dosing keeps IGF-1 more continuously elevated. Sermorelin users more commonly report deeper sleep and gradual body composition changes tied to the nightly pulse.

Weeks 8 to 12 and beyond

Most research protocols for both peptides run 8 to 12 weeks before a break, with reported body composition and recovery benefits building gradually across that window. Effects from either peptide fade within weeks of stopping, since neither creates a permanent change.

Results Timeline infographic comparing CJC-1295 and Sermorelin on a phone screen listing stages: Weeks 1-4, Weeks 4-8, and Weeks 8-12+.